ABL1 and lung adenocarcinoma: Notably, the treatment of mice bearing brain metastases with allosteric inhibitors of ABL tyrosine kinases, which are BBB-penetrant, impaired metastasis by decreasing the seeding and colonization of EGFR mutant lung adenocarcinoma cells in the brain parenchyma [52].